Cargando…

The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients

The development of innovative forms of combination drugs is closely related to the invention of the multilayer tablet press, polymers for pharmaceutical applications, the hot-melt extrusion process, and 3D printing in the pharmaceutical industry. However, combining multiple drugs within the same dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Janczura, Magdalena, Sip, Szymon, Cielecka-Piontek, Judyta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025674/
https://www.ncbi.nlm.nih.gov/pubmed/35456668
http://dx.doi.org/10.3390/pharmaceutics14040834
_version_ 1784690931423772672
author Janczura, Magdalena
Sip, Szymon
Cielecka-Piontek, Judyta
author_facet Janczura, Magdalena
Sip, Szymon
Cielecka-Piontek, Judyta
author_sort Janczura, Magdalena
collection PubMed
description The development of innovative forms of combination drugs is closely related to the invention of the multilayer tablet press, polymers for pharmaceutical applications, the hot-melt extrusion process, and 3D printing in the pharmaceutical industry. However, combining multiple drugs within the same dosage form can bring many physicochemical and pharmacodynamic interactions. More and more new forms of fixed-dose combinations (FDCs) have been developed due to work to overcome the incompatibility of active substances or to obtain different drug release profiles in the same dosage form. This review provides discussions of the application of various innovation formulation technologies of FDC drugs such as bilayer system, multilayer tablet, active film coating, hot-melt extrusion, and 3D printing, taking into account the characteristics of the key ingredients in the FDC formulation and presenting technological problems and challenges related to the development of combination drugs. Moreover, the article summarizes the range of dosage forms that have been made using these technologies over the past 30 years.
format Online
Article
Text
id pubmed-9025674
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90256742022-04-23 The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients Janczura, Magdalena Sip, Szymon Cielecka-Piontek, Judyta Pharmaceutics Review The development of innovative forms of combination drugs is closely related to the invention of the multilayer tablet press, polymers for pharmaceutical applications, the hot-melt extrusion process, and 3D printing in the pharmaceutical industry. However, combining multiple drugs within the same dosage form can bring many physicochemical and pharmacodynamic interactions. More and more new forms of fixed-dose combinations (FDCs) have been developed due to work to overcome the incompatibility of active substances or to obtain different drug release profiles in the same dosage form. This review provides discussions of the application of various innovation formulation technologies of FDC drugs such as bilayer system, multilayer tablet, active film coating, hot-melt extrusion, and 3D printing, taking into account the characteristics of the key ingredients in the FDC formulation and presenting technological problems and challenges related to the development of combination drugs. Moreover, the article summarizes the range of dosage forms that have been made using these technologies over the past 30 years. MDPI 2022-04-11 /pmc/articles/PMC9025674/ /pubmed/35456668 http://dx.doi.org/10.3390/pharmaceutics14040834 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Janczura, Magdalena
Sip, Szymon
Cielecka-Piontek, Judyta
The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients
title The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients
title_full The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients
title_fullStr The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients
title_full_unstemmed The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients
title_short The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients
title_sort development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025674/
https://www.ncbi.nlm.nih.gov/pubmed/35456668
http://dx.doi.org/10.3390/pharmaceutics14040834
work_keys_str_mv AT janczuramagdalena thedevelopmentofinnovativedosageformsofthefixeddosecombinationofactivepharmaceuticalingredients
AT sipszymon thedevelopmentofinnovativedosageformsofthefixeddosecombinationofactivepharmaceuticalingredients
AT cieleckapiontekjudyta thedevelopmentofinnovativedosageformsofthefixeddosecombinationofactivepharmaceuticalingredients
AT janczuramagdalena developmentofinnovativedosageformsofthefixeddosecombinationofactivepharmaceuticalingredients
AT sipszymon developmentofinnovativedosageformsofthefixeddosecombinationofactivepharmaceuticalingredients
AT cieleckapiontekjudyta developmentofinnovativedosageformsofthefixeddosecombinationofactivepharmaceuticalingredients